FDA Investigator

Makini Cobourne-Duval

Latest inspection on record: Kartepe, Turkey, December 2023 · records back to 2017

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 22 inspections across 22 sites are on record.
  • 11 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2023-12-06.

At a glance

Inspections

22

Sites

22

Observations

11

Career since

Mar 2017

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
DEVA HOLDING A S-KARTEPE URETIM TESISLERI6 Dec 2023Human Drugs
Lambda Therapeutic Research Ltd.24 Jan 2020Human DrugsOn file
Zenith Technology Corporation, Ltd.16 Jan 2020Human Drugs
Synchron Research Services Pvt. Ltd.22 Nov 2019Human DrugsOn file
Lupin Bioresearch Center15 Nov 2019Human Drugs

Sites inspected

Lambda Therapeutic Research Ltd.Ahmedabad, India1 insp.
Zenith Technology Corporation, Ltd.Dunedin, New Zealand1 insp.
Lupin Bioresearch CenterPune, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Amanda Lewin2 shared
Mohsen Rajabi Abhari2 shared
Li-Hong Yeh2 shared
Gopa Biswas2 shared
Mei Ou1 shared
Susanne M Richardson1 shared

Full investigator report

Get the verbatim findings behind Makini Cobourne-Duval's 11 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site